| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
S81486-5mg买3赠1 |
99.03% | ￥200.00 |
1 | - | - | - | - |
|
S81486-10mg买3赠1 |
99.03% | ￥240.00 |
3 | - | - | - | - |
|
S81486-25mg买3赠1 |
99.03% | ￥480.00 |
2 | - | - | - | - |
|
S81486-50mg买3赠1 |
99.03% | ￥850.00 |
2 | - | - | - | - |
|
S81486-100mg买3赠1 |
99.03% | ￥1600.00 |
3 | 2 | 2 | - | 2 |
|
S81486-1g |
99.03% | ￥5800.00 |
9 | - | - | - | - |
|
| 产品描述： | (-)-(S)-Equol is a high affinity ligand for estrogen receptor β with a Ki of 0.73 nM. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | Human Endogenous Metabolite;EstrogenReceptor/ERR; Estrogen/progestogenReceptor; EndogenousMetabolite | ||||||||||||||||||||
| 体内研究： | (-)-(S)-Equol inhibits the tumor growth by 43.2% and 28.4% compared to the control on day 33, suggesting that the compound is not overtly toxic | ||||||||||||||||||||
| 参考文献： | 1. Setchell KD, et al. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr. 2005 May;81(5):1072-9. 2. Lu Z, et al. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway. Curr Cancer Drug Targets. 2016;16(5):455-65. 3. Horiuchi H, et al. S-equol nantioselectively activates cAMP-protein kinase A signaling and reduces alloxan-induced cell death in INS-1 pancreatic β-cells. J Nutr Sci Vitaminol (Tokyo). 2014;60(4):291-6. | ||||||||||||||||||||
| 溶解性： | DMSO : 100 mg/mL (412.76 mM; Need ultrasonic and warming) | ||||||||||||||||||||
| 保存条件： | -20℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京